Sol-Gel reported a net loss of $0.4 million for the third quarter of 2024 and loss of $0.01 per basic and diluted share, compared to a net loss of $5.7 million and a loss of $0.21 per basic and ...
As more consumers seek solutions for redness-prone skin, the demand for effective, gentle ingredients is soaring. From environmental stressors to common irritants like acne and rosacea, sensitive skin ...
A third shared how they now 'can't do without the cream' in their morning routine and wrote: "I love this cream. It leaves my sensitive skin cool and hydrated. I have rosacea and the redness and ...
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...